HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Marth Selected Research

Platinum

8/2012Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients.
8/2006Combined PEG liposomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum-refractory and -resistant ovarian cancer after previous platinum-taxane therapy: a phase II Austrian AGO study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Marth Research Topics

Disease

17Ovarian Neoplasms (Ovarian Cancer)
11/2017 - 01/2000
16Neoplasms (Cancer)
10/2021 - 01/2000
10Carcinoma (Carcinomatosis)
01/2008 - 03/2000
7Breast Neoplasms (Breast Cancer)
10/2021 - 05/2000
5Ovarian Epithelial Carcinoma
11/2017 - 03/2000
4Endometrial Neoplasms (Endometrial Cancer)
01/2016 - 03/2003
2Disease Progression
01/2016 - 02/2009
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2008 - 01/2006
2Ascites
11/2000 - 03/2000
1Peritoneal Neoplasms
01/2018
1Pain (Aches)
11/2016
1Residual Neoplasm
01/2016
1Cystadenoma
01/2016
1Fever (Fevers)
10/2014
1Vomiting
10/2014
1Abdominal Pain (Pain, Abdominal)
10/2014
1Nausea
10/2014
1Prolapse
01/2008
1Dermatomyositis (Dermatopolymyositis)
01/2008
1Stomatitis
08/2006
1Peripheral Nervous System Diseases (PNS Diseases)
07/2006
1Adenocarcinoma
03/2003
1Hepatocellular Carcinoma (Hepatoma)
09/2001
1Urinary Retention
07/2001
1Noninfiltrating Intraductal Carcinoma (DCIS)
07/2000
1Neoplasm Metastasis (Metastasis)
07/2000
1Hematologic Neoplasms (Hematological Malignancy)
07/2000
1Carcinogenesis
05/2000

Drug/Important Bio-Agent (IBA)

5Paclitaxel (Taxol)FDA LinkGeneric
11/2017 - 03/2000
4Protein Isoforms (Isoforms)IBA
11/2011 - 07/2000
3Carboplatin (JM8)FDA LinkGeneric
11/2017 - 07/2006
3Proteins (Proteins, Gene)FDA Link
04/2010 - 03/2000
3Interferon-gamma (Interferon, gamma)IBA
07/2006 - 03/2000
3Messenger RNA (mRNA)IBA
11/2003 - 04/2000
3CytokinesIBA
07/2001 - 07/2000
2Estrogens (Estrogen)FDA Link
10/2021 - 02/2009
2liposomal doxorubicin (Doxil)FDA Link
08/2012 - 08/2006
2PlatinumIBA
08/2012 - 08/2006
2ErbB Receptors (EGF Receptor)IBA
09/2011 - 07/2000
2TamoxifenFDA LinkGeneric
02/2009 - 09/2000
2Cisplatin (Platino)FDA LinkGeneric
07/2006 - 03/2003
2Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2001 - 09/2000
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
07/2001 - 09/2000
2Tretinoin (Retinoic Acid)FDA LinkGeneric
04/2001 - 05/2000
2AntibodiesIBA
10/2000 - 03/2000
1Letrozole (Femara)FDA LinkGeneric
10/2021
1Hormones (Hormone)IBA
10/2021
1Tyrosine Kinase InhibitorsIBA
11/2017
1Analgesics (Analgesic Drugs)IBA
11/2016
1CreatinineIBA
01/2016
1Tumor Biomarkers (Tumor Markers)IBA
01/2016
1NeopterinIBA
01/2016
1catumaxomabIBA
10/2014
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
07/2013
1thiaclopridIBA
08/2012
11-dodecylpyridoxal (PLD)IBA
08/2012
1gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
04/2012
1E2F3 Transcription FactorIBA
09/2011
1Zoledronic Acid (Zometa)FDA Link
02/2009
1Anastrozole (Arimidex)FDA LinkGeneric
02/2009
1Goserelin (Zoladex)FDA Link
02/2009
1Antineoplastic Agents (Antineoplastics)IBA
01/2008
1GemcitabineFDA Link
08/2006
1taxaneIBA
08/2006
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2006
1Coloring Agents (Dyes)IBA
01/2006
12,5-dichloro-4-bromophenol (B 2)IBA
01/2006
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2003
1IntegrinsIBA
08/2002
1cisatracurium (Nimbex)FDA Link
09/2001
1AnthracyclinesIBA
09/2001
1Trastuzumab (Herceptin)FDA Link
09/2001
1Atracurium (Tracrium)FDA Link
09/2001
1Polypropylenes (Polypropylene)IBA
07/2001
1sodium bisulfiteFDA Link
04/2001
1AntigensIBA
11/2000
1Cytostatic AgentsIBA
10/2000
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2000
1Transcription Factors (Transcription Factor)IBA
10/2000
1LigandsIBA
10/2000
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2000
1Pharmaceutical PreparationsIBA
09/2000
1Transforming Growth Factor beta (TGF-beta)IBA
07/2000
1Epidermal Growth Factor (EGF)IBA
07/2000
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
07/2000
1Keratin-19 (Keratin 19)IBA
07/2000
1DecitabineFDA Link
05/2000

Therapy/Procedure

10Therapeutics
11/2017 - 03/2000
8Drug Therapy (Chemotherapy)
01/2018 - 01/2000
1Combination Drug Therapy (Combination Chemotherapy)
11/2017
1Hyperthermic Intraperitoneal Chemotherapy
02/2016
1Radiotherapy
01/2016
1Cytoreduction Surgical Procedures
10/2014
1Chemoradiotherapy
01/2008
1Drug Tapering
08/2006
1Lymph Node Excision (Lymph Node Dissection)
01/2006
1Hysterectomy
01/2006
1Second-Look Surgery
01/2002
1Operative Surgical Procedures
07/2001
1Suburethral Slings (Tension-Free Vaginal Tape)
07/2001